Navinci Diagnostics AB is a Swedish AB based in Uppsala, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2004, the company reported revenue of SEK 18.2m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva utveckling, produktion, marknadsföring och försäljning av bioteknologiska produkter och tjänster och därmed förenlig verksamhet.
In its most recent annual report (2025), Navinci Diagnostics AB reported revenue of SEK 18.2m, an increase of 72% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 38.7m, and the EBITDA margin stood at -199.8%.
At the end of 2025, equity financed 87.4% of the balance sheet, and current assets covered short-term debt 7.4 times.
Frequently asked questions
What is the Org number of Navinci Diagnostics AB?
Navinci Diagnostics AB is registered with Bolagsverket / SCB under Org 5566636998.
What is the revenue of Navinci Diagnostics AB?
Navinci Diagnostics AB reported revenue of SEK 18.2m in 2025.
Who is the CEO of Navinci Diagnostics AB?
Jenny Sundqvist is the CEO of Navinci Diagnostics AB, in role since 2024.
Who is the chairman of Navinci Diagnostics AB?
Eva Kristina Pisa chairs the board of Navinci Diagnostics AB, in role since 2020.
Where is Navinci Diagnostics AB headquartered?
Navinci Diagnostics AB's registered address is Dag Hammarskjölds Väg 52 A.
